首页> 美国卫生研究院文献>Molecular Cancer >miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6
【2h】

miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6

机译:miR-211通过靶向Cyclin D1和CDK6抑制上皮性卵巢癌的增殖和细胞周期进程

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundEpithelial ovarian cancer (EOC) is a significant cause of morbidity and mortality. MicroRNAs play important roles in cancer development and progression. The microRNA miR-211 is localized on intron 6 of the Trpm1 gene at 15q13-q14, a locus that is frequently lost in neoplasms. Its function and loss-of-function have been described in normal and cancer cells and tissues. miR-211 is known to be dysregulated in ovarian cancer: however, its function and the downstream effect of its loss-of-function in ovarian cancer have not been described before.
机译:背景上皮性卵巢癌(EOC)是发病率和死亡率的重要原因。 MicroRNA在癌症的发展和进程中起着重要的作用。 microRNA miR-211位于Trpm1基因的6号内含子,位于15q13-q14,这是一个在肿瘤中经常丢失的基因座。在正常细胞和癌细胞以及组织中已经描述了其功能和功能丧失。已知miR-211在卵巢癌中失调:但是,其功能及其在卵巢癌中功能丧失的下游作用尚未见过描述。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号